{"title":"Nonalcoholic fatty liver disease and metabolic syndrome","authors":"G. Xi","doi":"10.3760/CMA.J.ISSN.1673-4157.2006.02.001","DOIUrl":null,"url":null,"abstract":"Nonalcoholic fatty liver disease(NAFLD)comprises a disease spectrum which includes variable degrees of simple steatosis nonalcoholic steatohepatitis(NASH) and cirrhosis even liver failure and patocellular carcinoma.NAFLD can be considered the hepatic manifestation of the metabolic syndrome and is an independent predictor of type 2 diabetes(T2DM) and cardiovascular disease(CVD).Insulin resistance is the pathogenetic link between the metabolic syndrome and fat accumulation in the liver.Patients with NAFLD are a high risk population of the both of diseases.It's very important significance to early diagnosis and treatment of NAFLD for prevention T2DM and CVD.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2006-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国实用内科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-4157.2006.02.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Nonalcoholic fatty liver disease(NAFLD)comprises a disease spectrum which includes variable degrees of simple steatosis nonalcoholic steatohepatitis(NASH) and cirrhosis even liver failure and patocellular carcinoma.NAFLD can be considered the hepatic manifestation of the metabolic syndrome and is an independent predictor of type 2 diabetes(T2DM) and cardiovascular disease(CVD).Insulin resistance is the pathogenetic link between the metabolic syndrome and fat accumulation in the liver.Patients with NAFLD are a high risk population of the both of diseases.It's very important significance to early diagnosis and treatment of NAFLD for prevention T2DM and CVD.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
